316 related articles for article (PubMed ID: 8609223)
1. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
2. Complementation analysis of fibroblasts from peroxisomal fatty acid oxidation deficient patients shows high frequency of bifunctional enzyme deficiency plus intragenic complementation: unequivocal evidence for differential defects in the same enzyme protein.
van Grunsven EG; van Roermund CW; Denis S; Wanders RJ
Biochem Biophys Res Commun; 1997 Jun; 235(1):176-9. PubMed ID: 9196058
[TBL] [Abstract][Full Text] [Related]
3. Biochemical findings in a series of Australian patients with isolated defects in peroxisomal beta-oxidation.
Paton BC; Sharp PC; Poulos A
Ann N Y Acad Sci; 1996 Dec; 804():750-1. PubMed ID: 8993614
[No Abstract] [Full Text] [Related]
4. Urinary bile acids and peroxisomal bifunctional enzyme deficiency.
Natowicz MR; Evans JE; Kelley RI; Moser AB; Watkins PA; Moser HW
Am J Med Genet; 1996 May; 63(2):356-62. PubMed ID: 8725785
[TBL] [Abstract][Full Text] [Related]
5. Complementation analysis of patients with intact peroxisomes and impaired peroxisomal beta-oxidation.
McGuinness MC; Moser AB; Poll-The BT; Watkins PA
Biochem Med Metab Biol; 1993 Apr; 49(2):228-42. PubMed ID: 8484962
[TBL] [Abstract][Full Text] [Related]
6. Peroxisomal bifunctional enzyme deficiency.
Watkins PA; Chen WW; Harris CJ; Hoefler G; Hoefler S; Blake DC; Balfe A; Kelley RI; Moser AB; Beard ME
J Clin Invest; 1989 Mar; 83(3):771-7. PubMed ID: 2921319
[TBL] [Abstract][Full Text] [Related]
7. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
8. Neuronal migration abnormality in peroxisomal bifunctional enzyme defect.
Kaufmann WE; Theda C; Naidu S; Watkins PA; Moser AB; Moser HW
Ann Neurol; 1996 Feb; 39(2):268-71. PubMed ID: 8967760
[TBL] [Abstract][Full Text] [Related]
9. D-hydroxyacyl-CoA dehydrogenase deficiency. Identification of a new peroxisomal disorder with implications for other disorders of beta-oxidation.
van Grunsven EG; van Berkel E; Denis S; Mooijer PA; Wanders RJ
Adv Exp Med Biol; 1999; 466():365-9. PubMed ID: 10709664
[TBL] [Abstract][Full Text] [Related]
10. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid mediates peroxisomal elongation, a prerequisite for peroxisome division.
Itoyama A; Honsho M; Abe Y; Moser A; Yoshida Y; Fujiki Y
J Cell Sci; 2012 Feb; 125(Pt 3):589-602. PubMed ID: 22389399
[TBL] [Abstract][Full Text] [Related]
12. A bifunctional protein with deficient enzymic activity: identification of a new peroxisomal disorder using novel methods to measure the peroxisomal beta-oxidation enzyme activities.
Wanders RJ; van Roermund CW; Schelen A; Schutgens RB; Tager JM; Stephenson JB; Clayton PT
J Inherit Metab Dis; 1990; 13(3):375-9. PubMed ID: 2122104
[No Abstract] [Full Text] [Related]
13. Peroxisomal bifunctional enzyme deficiency with associated retinal findings.
Al-Hazzaa SA; Ozand PT
Ophthalmic Genet; 1997 Jun; 18(2):93-9. PubMed ID: 9228246
[TBL] [Abstract][Full Text] [Related]
14. Distinction between peroxisomal bifunctional enzyme and acyl-CoA oxidase deficiencies.
Watkins PA; McGuinness MC; Raymond GV; Hicks BA; Sisk JM; Moser AB; Moser HW
Ann Neurol; 1995 Sep; 38(3):472-7. PubMed ID: 7668838
[TBL] [Abstract][Full Text] [Related]
15. [Bifunctional enzyme deficiency].
Suzuki Y
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):326-7. PubMed ID: 9645073
[No Abstract] [Full Text] [Related]
16. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional enzyme deficiency: identification of a new type of peroxisomal disorder in a patient with an impairment in peroxisomal beta-oxidation of unknown aetiology by means of complementation analysis.
Wanders RJ; van Roermund CW; Brul S; Schutgens RB; Tager JM
J Inherit Metab Dis; 1992; 15(3):385-8. PubMed ID: 1357231
[No Abstract] [Full Text] [Related]
18. Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids.
Baes M; Huyghe S; Carmeliet P; Declercq PE; Collen D; Mannaerts GP; Van Veldhoven PP
J Biol Chem; 2000 May; 275(21):16329-36. PubMed ID: 10748062
[TBL] [Abstract][Full Text] [Related]
19. Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis.
Suzuki Y; Shimozawa N; Yajima S; Tomatsu S; Kondo N; Nakada Y; Akaboshi S; Lai M; Tanabe Y; Hashimoto T
Am J Hum Genet; 1994 Jan; 54(1):36-43. PubMed ID: 8279468
[TBL] [Abstract][Full Text] [Related]
20. Aberrant peroxisome morphology in peroxisomal beta-oxidation enzyme deficiencies.
Funato M; Shimozawa N; Nagase T; Takemoto Y; Suzuki Y; Imamura Y; Matsumoto T; Tsukamoto T; Kojidani T; Osumi T; Fukao T; Kondo N
Brain Dev; 2006 Jun; 28(5):287-92. PubMed ID: 16376506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
